Thursday, May 2, 2019

Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 02, 2019, titled "Alembic Pharmaceuticals receives USFDA Approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2%.".

from Moneycontrol http://bit.ly/2XXMAXN

No comments:

Post a Comment

Trading Books